Lee Goldman, MD - Taiwan Society of Internal Medicine
Lee Goldman, MD - Taiwan Society of Internal Medicine
Lee Goldman, MD - Taiwan Society of Internal Medicine
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
209. Ganz DA, Lamas GA, Orav EJ, <strong>Goldman</strong> L, Gutierrez PR, Mangione CM. Age-related<br />
differences in management <strong>of</strong> heart disease: A study <strong>of</strong> cardiac medication use in an<br />
older cohort. J Am Ger Soc 1999;47:145-150.<br />
210. <strong>Goldman</strong> L, Coxson P, Hunink MGM, <strong>Goldman</strong> PA, Tosteson ANA, Mittleman M,<br />
Williams L, Weinstein MC. The relative influence <strong>of</strong> secondary versus primary<br />
prevention using the National Cholesterol Education Program Adult Treatment Panel II<br />
Guidelines. J Am Coll Card 1999;34:768-776.<br />
211. <strong>Lee</strong> TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF,<br />
Sugarbaker DJ, Donaldson MC, Poss R, Ho KLK, Ludwig LE, Pedan A, <strong>Goldman</strong> L.<br />
Derivation and prospective validation <strong>of</strong> a simple index for prediction <strong>of</strong> cardiac risk <strong>of</strong><br />
major noncardiac surgery. Circulation 1999;100:1043-1049.<br />
212. Gillman MW, Ross-Degnan D, McLaughlin TJ, Gao X, Spiegelman D, <strong>Goldman</strong> L,<br />
Soumerai SB. Effects <strong>of</strong> long-acting vs. short-acting calcium channel blockers among<br />
elderly survivors <strong>of</strong> acute myocardial infarction. J Am Geriatr Soc 1999;47:512-517.<br />
213. Oliver MF, <strong>Goldman</strong> L, Julian DG, Holme I for the Mivazerol Trial Investigators<br />
Research Group. Effect <strong>of</strong> mivazerol on perioperative cardiac complications during noncardiac<br />
surgery in patients with coronary heart disease: The European mivazerol trial<br />
(EMIT). Anesthesiology 1999;91:951-961.<br />
214. Kuntz KM, Tsevat J, Weinstein MC, <strong>Goldman</strong> L. Expert panel vs. decision analysis<br />
recommendations for postdischarge coronary angiography after myocardial infarction.<br />
JAMA 1999;282:2246-2251.<br />
215. Phillips RS, Hamel MB, Teno JM, Soukup J, Lynn J, Califf R, Vidaillet H, Davis RB,<br />
<strong>Goldman</strong> L. Patient race and decisions to withhold or withdraw life-sustaining<br />
treatments for seriously ill hospitalized adults. Am J Med 2000;108:14-19.<br />
216. Prosser LA, Stinnett AA, <strong>Goldman</strong> PA, Williams LW, Hunink MGM, <strong>Goldman</strong> L,<br />
Weinstein MC. Cost-effectiveness <strong>of</strong> cholesterol-lowering therapies according to<br />
selected patient characteristics. Ann Intern Med 2000;132:769-779.<br />
217. Auerbach AD, Hamel MB, Davis RB, Connors AF, Regueiro C, Desbiens N, <strong>Goldman</strong> L,<br />
Califf RM, Dawson NV, Wenger N, Vidaillet H, Phillips RS. For the SUPPORT<br />
investigators. A comparison <strong>of</strong> generalist and cardiologist care for seriously ill<br />
hospitalized patients with congestive heart failure: Costs, resource use, and survival.<br />
Ann Intern Med 2000;132:191-200.<br />
218. Lamas GA, <strong>Lee</strong> K, Sweeney M, Leon A, Yee R, Ellenbogen K, Greer S, Wilber D,<br />
Silverman R, Marinchek R, Bernstein R, McAnulty J, Mittelman R, Sullivan C, Zorn L,<br />
Flaker G, Schron E, Orav EJ, <strong>Goldman</strong> L. Mode Selection Trial (MOST) in sinus node<br />
dysfunction: Design, rationale, and baseline patient characteristics <strong>of</strong> the first 1000<br />
patients. Am Heart J 2000;140:541-551<br />
219. Ellenbogen KA, Stambler BS, Orav EJ, Sgarbossa EB, Tullo NG, Love CA, Wood MA,<br />
<strong>Goldman</strong> L, Lamas GA and the Pacemaker Selection in the Elderly (PASE) Trial<br />
27
Change language